Anxiety Insomnia
Conditions
Interventions
experimental group:Using acupuncture at the "ghost point" method for treatment. Once every other day, three times a week, and one course of treatment for four weeks, for a total of three courses of tr
control group:Oral treatment of flupenthixone and melitracin tablets. 1 tablet per dose, 2 times per day, once in the morning and once in the evening, for 4 weeks as a course of treatment, for a total
Sponsors
Taizhou Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients who met the diagnostic criteria for insomnia in the "Diagnosis and Treatment Guidelines for Insomnia in China" formulated by the Chinese Sleep Research Association in 2017, as well as the diagnostic criteria for generalized anxiety in the fifth edition of the "Diagnostic and Statistical Manual for Mental Disorders" formulated by the American Psychiatric Association. 2.Subjects with PSQI score of more than 7; 3.Subjects wit HAMA score =14 and<29; 4.Subjects aged 18-65 years old, Male or Female; 5.Disease duration = 6 months; 6.Normal physical condition, clear mind, normal expression ability, junior high school education or above, without significant visual or hearing impairment that may affect the assessment; 7.The patients were informed of the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women. 2. Subjects with evidence of alcohol or other substance dependence or abuse. 3. Patients with severe aphasia and agnosia who are unable to communicate. 4. Patients with organic diseases and mental diseases, or secondary insomnia caused by drugs, etc; Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, and psychotic patients. 5. Patients with diseases that are contraindicated for the use of cefoperazone and melitracin, such as hyperthyroidism, atrioventricular block, myasthenia gravis, etc; 6. Patients undergoing other treatment options.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index total score;Hamilton Anxiety Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability indicator;Content of substance P and neuropeptide Y in serum; | — |
Countries
China
Contacts
Public ContactYan Lichao
Taizhou Traditional Chinese Medicine Hospital
Outcome results
None listed